Nithin Kamath Warns of Inflation Risks From Weak Monsoon and Geopolitical Tensions Tesla Expands Full SelfDriving Supervised to China as Domestic EV Rivals Accelerate Autonomous Tech European Companies Pursue Reindustrialisation Amid Declining Investment Plans and AIs Growing Economic Role GD Holdings Acquires 16 St Regis Chicago Condos from Sony in 21M Transaction Traders Skeptical of Irans Strait of Hormuz Reopening Timeline Moroccos Push for Western Sahara Tourism Raises Geopolitical and Investment Questions OGN Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain HNVR Q1 2026 Earnings Slight EPS Miss Amid Challenging Operating Environment WEC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response HRB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction FCBC Q1 2026 Earnings Slight EPS Miss Amid Flat Revenue Stock Inches Higher BNAI Q3 2025 Earnings EPS Beat Surprises Market but Revenue Remains Absent Contango ORE Inc CTGO Slides 46 Testing Near Support as Sector Weakness Weighs Ironwood Pharmaceuticals IRWD Edges Higher Can It Hold Above Key Support Drugs Made In America Acquisition Corp DMAA Holds Steady Near Support as SPAC Market Awaits Catalyst TE Connectivity TEL Edges Higher as Stock Stabilizes Near Key Support Levels Rezolve AI Warrants RZLVW Edge Higher Amid Low Volume Key Levels to Watch ABC Challenges FCC Renewal Process Files Early Station License Applications Amid Controversy CINT Q1 2026 Earnings EPS Misses Estimates Stock Rises on Optimism Adamas Trust 9875 Senior Notes ADAMH Edge Higher as Yield Attracts Steady Demand Camtek Shares Surge 3 as Momentum Builds Toward Key Resistance Bitdeer Technologies BTDR Slides 181 to 1465 as Trading Volume Highlights Sector Pressure Xcel Energy XEL Gains Ground Near Key Support as Utilities Sector Shows Resilience AUTL Flatlines at 168 Autolus Therapeutics Consolidates Near Key Support Hinge Health HNGE Drops 41 Approaches Key Support at 5033 Palvella Therapeutics PVLA Gains 2 as Stock Approaches Key Resistance Level Kymera Therapeutics KYMR Shows Modest Upside as Biotech Sector Stabilizes